AlgaVac

AlgaVac develops microalgae-based oral vaccines and disease treatments for sustainable aquaculture.

Health Tech & Life Sciences
Active
Pre-Funding Kibbutz Gan Shmuel, Israel
Website ↗ LinkedIn
Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
—
Headcount
3
HQ
Kibbutz Gan Shmuel, Israel
Sector
Health Tech & Life Sciences

About

AlgaVac is an Israeli startup focused on promoting global food security and environmental sustainability in aquaculture. The company's breakthrough technology provides environmentally friendly oral vaccines and disease treatments using microalgae biomass powder, replacing traditional injectables and plastics. This approach aims to combat the significant disease-related fish loss in aquaculture and expand treatment options to crustaceans and mollusks.

Q&A

What is AlgaVac's primary focus?
AlgaVac is an aquaculture biotechnology company that develops an algae-based oral delivery platform for vaccines and disease treatments in fish and other aquaculture species.
How does AlgaVac's technology work?
The company uses genetically transformed microalgae as a cell-based production and bio-encapsulation system. This creates an algal powder that can be mixed into feed to deliver vaccines through regular feeding.
What problem does AlgaVac's platform aim to solve in aquaculture?
AlgaVac's platform is designed to reduce reliance on manual injectable vaccination, plastic medical consumables, and handling-intensive disease prevention methods in aquaculture.
When was AlgaVac founded?
AlgaVac was founded in November 2022.
What is AlgaVac's current funding stage?
AlgaVac is currently in the Pre-Funding stage.
With which organizations has AlgaVac reported proof-of-concept collaborations?
AlgaVac has reported proof-of-concept collaborations with Virbac, Temasek Polytechnic, and Israel’s Agricultural Research Organization.
What are the applications of AlgaVac's proof-of-concept collaborations?
The proof-of-concept collaborations include oral fish vaccine and growth-promoting applications.

Team · 1

Maor Sasson
Founder · Founder and CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life Sciences
Business model
B2B

Tags

vaccines-developmentaquaculturealgae-products
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)